Abstract
Objective: We have reviewed the potential cancer-preventive and other relevant properties of Panax ginseng C. A. Meyer, which has been traditionally used as a natural tonic in Oriental countries.
Data identification and study selection: Publications on Panax ginseng and its relation to cancer were obtained from the Medline database (1983–1998) and by checking reference lists to find earlier reports. The reports cover experimental models and human studies on cancer-preventive activity, carcinogenicity and other beneficial or adverse effects. In addition, possible mechanisms of chemoprevention by ginseng were considered.
Results: Published results from a cohort and two case–control studies in Korea suggest that the intake of ginseng may reduce the risk of several types of cancer. When ginseng was tested in animal models, a reduction in cancer incidence and multiplicity at various sites was noted. Panax ginseng and its chemical constituents have been tested for their inhibiting effect on putative carcinogenesis mechanisms (e.g., cell proliferation and apoptosis, immunosurveillance, angiogenesis); in most experiments inhibitory effects were found.
Conclusion: While Panax ginseng C. A. Meyer has shown cancer-preventive effects both in experimental models and in epidemiological studies, the evidence is currently not conclusive as to its cancer-preventive activity in humans. The available evidence warrants further research into the possible role of ginseng in the prevention of human cancer and carcinogenesis.
Similar content being viewed by others
References
Wen J, Zimmer EA (1996) Phylogeny and biogeography of Panax L. (the ginseng genus, Araliaceae): inferences from ITS sequences of nuclear ribosomal DNA. In: Molecular Phylogenetics and Evolution 6: 167–177.
Tanaka O, Kasai R, Norita T (1986) Chemistry of ginseng and related plants. Rec Adv Abstr Chinese Med 1: 130–152.
Hu SY (1976) The genus Panax (ginseng) in Chinese medicine. Econ Bot 30: 11–28.
Liu CX, Xiao PG (1992) Recent advances on ginseng research in China. J Ethnopharmacol 36: 27–38.
Cui J, Garle P, Bjorkhem I (1994) What do commercial ginseng preparations contain? Lancet 344: 134.
Siegel RK (1979) Ginseng abuse syndrome. Problems with the panacea. JAMA 241: 1614–1615.
Park JD (1996) Recent studies on the chemical constituents of Korean ginseng (Panax ginseng C. A. Meyer). Korean J Ginseng Sci 20: 389–415.
Yun TK, Choi SY, Lee YS, eds (1997) Nontoxic and Nonorgan Specific Cancer Preventive Effect of Panax ginseng C. A. Meyer. In Shibamoto T, Tirao J, Osawa T, eds. ACS Symposium series 702: Functional foods for disease prevention II, Medicinal plants and other foods. California: 162–177.
Scaglione F, Cogo R, Cucuzza C, Arcidacono M, Beretta A (1994) Immunomodulatory effects of Panax ginseng C. A. Meyer (G115) on alveolar macrophages from patients suffering with chronic bronchitis. Int J Immunother 10: 21–24.
Zhang GD, Zhou ZH, Wang MZ, Gao FY (1980) Analysis of ginseng. II. Acta Pharm Sinica 15: 175–181.
Xu SX, Wang NL, Shen M, Lu XK (1986) Studies on the chemical constituents of saponins of the stems and leaves of Panax ginseng C. A. Meyer. Acta Bot Sinica 28: 95–101.
Zhang GD, Zhou ZH, Gao FY (1979) Analysis of ginseng. I. Acta Pharm Sinica 14: 309–314.
Yun TK, Yun YS, Han IW (1980) An experimental study on tumor inhibitory effect of red ginseng in mice and rats exposed to various chemical carcinogens. In: 3rd International Ginseng Symposium; 1980; Seoul: Korea Ginseng Research Institute Press, pp. 87–113.
Yun TK, Yun YS, Han IW (1983) Anticarcinogenic effect of long-term oral administration of red ginseng on newborn mice exposed to various chemical carcinogens. Cancer Detect Prev 6: 515–525.
Yun TK, Kim SH, Oh YR (1987) Medium-term (nine week) method for assay of preventive agents against tumors. J Korean Cancer Res 19: 1–7.
Yun TK, Kim SH (1988) Inhibition of development of benzo(a)pyrene-induced mouse pulmonary adenoma by natural products medium-term bioassay system. J Korean Cancer Assoc 20: 133–142.
Yun TK, Kim SH, Lee YS (1995) Trial of a new medium-term model using benz(a)pyrene induced lung tumor in newborn mice. Anticancer Res 15: 839–846.
Yun TK (1996) Experimental and epidemiological evidence of the cancer-preventive effects of Panax ginseng C. A. Meyer. Nutr Rev 54: S71–S81.
Yun TK, Lee YS (1994) Anticarcinogenic effect of ginseng powders depending on the types and ages using Yun's anticarcinogenicity test (I). Korean J Ginseng Sci 18: 89–94.
Yun TK, Lee YS (1994) Anticarcinogenic effect of ginseng powders depending on the types and ages using Yun's anticarcinogenicity test (II). Korean J Ginseng Sci 18: 160–164.
Lee YS, Chung IS, Lee IR, Kim KH, Hong WS, Yun YS (1997) Activation of multiple effector pathway of immune system by the antineoplastic immunostimulator acidic polysaccharide ginsan isolated from Panax ginseng. Anticancer Res 17: 323–332.
You M, Bergman G (1998) Preclinical and clinical models of lung cancer chemoprevention. Hematol/Oncol Clin N Am 12: 1037–1053.
Wu XG, Zhu DH (1990) Influence of ginseng upon the development of liver cancer induced by diethylnitrosamine in rats. J Tongji Med Univ 10: 141–145.
Li X, Wu XG (1991) Effects of ginseng on hepatocellular carcinoma in rats induced by diethylnitrosamine-a further study. J Tongji Med Univ 11: 72–80.
Kim JP, Park JG, Lee MD, et al. (1985) Co-carcinogenic effects of several Korean foods on gastric cancer induced by N-methyl-N′-nitro-N-nitrosoguanidine in rats. Jpn J Surg 15: 427–437.
Nagata H, Kikuchi Y, Tode T, et al. (1998) Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells. Jpn J Cancer Res 89: 733–740.
Kikuchi Y, Sasa H, Kita T, Hirata J, Tode T, Nagata I (1991) Inhibition of human ovarian cancer cell proliferation in vitro by ginsenoside Rh2 and adjuvant effects to cisplatin in vivo. Anti-cancer Drugs 2: 63–67.
Tode T, Kikuchi Y, Kita T, Hirata J, Imaizumi E, Nagata I (1993) Inhibitory effects by oral administration of ginsenoside Rh2 on the growth of human ovarian cancer cells in nude mice. J Cancer Res Clin Oncol 120: 24–26.
Chen Xiaoguang, Liu Hongyan, Lei Xiaohong, et al. (1998) Cancer chemopreventive and therapeutic activities of red ginseng. J Ethnopharmacol 60: 71–78.
Bespalove VG, Davydov VV, Limarenko AY, Slenpyan LI, Aleksandrov VA (1993) Inhibition of the development of experimental uterus cervix and vaginal tumors by tinctures from biomasses of cultivated cells of ginseng and its germanium-selective stocks. Biull Eksp Biol Med 116: 534–536.
Bespalove VG, Alexandrov VA, Davydov VV, et al. (1993) Inhibition of mammary gland carcinogenesis using a tincture from biomass of ginseng tissue culture. Biull Eksp Biol Med 115: 59–61.
Yun TK, Choi SY (1990) A case-control study of ginseng intake and cancer. Int J Epidemiol 19: 871–876.
Yun TK, Choi SY (1995) Preventive effect of ginseng intake against various human cancers: a case-control study on 1987 pairs. Cancer Epidemiol Biomarkers Prev 4: 401–408.
Berg JW, Ross R, Latourette HB (1997) Economic status and survival of cancer patients. Cancer 39: 467–477.
Yun TK, Choi SY, Lee YS (1995) A prospective study on ginseng intake and cancer for population-Preliminary report. Korean J Ginseng Sci 19: 87–92.
Yun TK, Choi SY (1998) Non-organ specific cancer prevention of ginseng: a prospective study in Korea. Int J Epidemiol 27: 359–364.
Yeung HW, Cheung K, Leung KL (1982) Immunopharmacology of Chinese medicine. 1: Ginseng-induced immunosuppression in virus-infected mice. Am J Chinese Med X: 44–54.
Singh VK, Agarwal SS, Gupta BM (1984) Immunomodulatory activity of Panax ginseng extract. Planta Med 50: 462–465.
Jie YH, Cammisuli S, Baggiolini M (1984) Immunomodulatory effects of Panax ginseng C. A. Meyer in the mouse. Agents Actions 15: 386–391.
Yang GZ, Bao T, Geng PL (1986) The immunoregulatory effect of ginsenoside in vivo and in vitro. J Trad Chinese Med 6: 191–194.
Yang GZ, Yu YL (1988) Effects of ginsenoside on the natural killer cell-interferon-interlukin-2 regulatory network and its tumor inhibiting effect. J Trad Chinese Med 8: 135–140.
Yang GZ, Yu YL (1990) Immunopotentiating effect of traditional Chinese drugs-ginsenoside and glycyrrhiza polysaccharide. Proc CAMS PUMC 5: 188–193.
Yun YS, Jo SK, Moon HS, Kim YJ, Oh YR, Yun TK (1987) Effect of red ginseng on natural killer cell activity in mice with lung adenoma induced by urethane and benzo(a)pyrene. Cancer Detect Prev 26: 301–309.
Yun YS, Lee YS, Jo SK, Jung IS (1993) Inhibition of autochthonous tumor by ethanol insoluble fraction from Panax ginseng as an immunomodulator. Plant Med 59: 521–524.
Kenarova B, Neychev H, Hadjiivanova C, Petkov VD (1990) Immunomodulating activity of ginsenoside Rg1 from Panax ginseng. Jpn J Pharmacol 54: 447–454.
Mizuno M, Yamada J, Terai H, Kozukue N, Lee YS, Tsuchida H (1994) Differences in immunomodulation effects between wild and cultured Panax ginseng. Biochem Biophys Res Commun 200: 1672–1678.
Kim JY, Gemolec DR, Luster MI (1990) Panax ginseng as a potential immunomodulator: studies in mice. Immunopharmacol Immunotoxicol 12: 257–276.
Abdrasilov BS, Kim YA, Nurieva RI, et al. (1996) The effect of total saponins from Panax ginseng C. A. Meyer on the intracellular signaling system in Ehrlich ascites tumor cells. Biochem Molec Int 38: 519–526.
Park MK, Hwang WI (1996) Effects of the petroleum-ether extracts of ginseng on the cell cycle and protein kinase C activity in cancer cells. Korean J Ginseng Sci 20: 219–225.
Shin EK, Park HW, Kim SC, Jung NP (1996) The effects of ginseng components on the signal transduction in the activation of murine macrophages. Korean J Ginseng Sci 20: 159–167.
Fan ZH, Isobe L, Kiuchi K, Nakashima I. Enhancement of nitric oxide production from activated macrophages by a purified from of ginsenoside (Rg1). Am J Chinese Med 23: 279–287.
Kim YH, Park KH, Rho HM (1996) Transcriptional activation of the Cu, Zn-superoxide dismutase gene through the AP2 site by ginsenoside Rb2 extracted from a medicinal plant, Panax ginseng. J Biol Chem 271: 24539–24543.
Umnova NV, Michurina TL, Smironova NI, Aleksandrova IV, Poroshenko GG (1991) In vitro and in vivo studies of bioginseng antimutagen properties in mammalian cells. Biull Eksp Biol Med 111: 507–509.
Rhee TH, Ahn JH, Choe J, Kang KW, Joe C (1991) Inhibition of mutagenesis and transformation by root extracts of Panax ginseng in vitro. Planta Med 57: 125–128.
Sato K, Mochizuki M, Saiki I, Yoo YC, Samukawa K, Azuma I (1994) Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, Ginsenoside-Rb2. Biol Pharmacol Bull 17: 635–639.
Mochizuki M, Yoo YC, Matsuzawa K, et al. (1995) Inhibitory effect of tumor metastasis in mice by saponins Ginsenoside-Rb2, 20(R)-and 20(S)-ginsenoside Rg3, of Red ginseng. Biol Pharm Bull 18: 1197–1202.
Shinkai K, Akedo H, Mukai M, et al. (1996) Inhibition of in vitro tumor cell invasion by ginsenoside Rg3. Jpn J Cancer Res 87: 357–362.
Palmer BV, Montgomery ACV, Monterio JCMP (1978) Ginseng and mastalgia [letter]. BMJ 1: 1284.
Punnone R, Lukola A (1978) Oestrogen like effect of ginseng [letter]. BMJ 1: 1284.
Greenspan EM (1983) Ginseng and vaginal bleeding [letter]. JAMA 249: 2018.
Hopkins MP, Andro. L, Beningsho. AS (1988) Ginseng face-cream and unexplained vaginal bleeding. Am J Obstet Gynecol 159: 1121–1122.
Korieh OM (1978) Ginseng and mastalgia [letter]. BMJ 1: 1284.
Albertsson M, Seiving B (1996) Adverse effect of ginseng: no cure in breast cancer. Läkartidninten 93: 2670–2672.
Ryu SJ, Chien YY (1995) Ginseng-associated cerebral arteritis. Neurology 45: 829–830.
Dega H, Larte JL, Frances C, Herson S, Chosidow O (1996) Ginseng as a cause for Stevens-Johnson syndrome? Lancet 347: 1344.
Faleni R, Soldati F (1996) Ginseng as cause of Stevens-Johnson syndrome? Lancet 348: 267.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shin, H.R., Kim, J.Y., Yun, T.K. et al. The cancer-preventive potential of Panax ginseng: a review of human and experimental evidence. Cancer Causes Control 11, 565–576 (2000). https://doi.org/10.1023/A:1008980200583
Issue Date:
DOI: https://doi.org/10.1023/A:1008980200583